Nanite, Inc.
PrivateLast Round
Grant
May 8, 2024
Total Funding Raised
$11.9M
Company Overview
Nanite, Inc. is a biotechnology company that develops programmable polymer nanoparticles for non-viral gene delivery using an AI-driven platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanite, Inc. Comparables
Compare Nanite, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Envoya | 86% | |
| Liberate Bio | 83% | |
| Hopewell Therapeutics | 83% | |
Nanite, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 8, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Grant | Aug 10, 2023 | ||||
| Grant | Mar 15, 2023 | ||||
| Seed | Feb 15, 2023 |
Key People
Founding team and executive leadership
Nanite, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zetta Venture Partners | Seed |
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Cystic Fibrosis Foundation | Grant |
| Arkitekt Ventures | Seed |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2024
Secured $1.8M from the Gates Foundation.
- Feb 15, 2023
$6M round led by Zetta Venture Partners.
Nanite, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanite, Inc.'s valuation, stock price, and market status.